読み込み中
Clarivate Plc operates as a prominent information services and analytics firm, furnishing structured data and insights. Its core mission is to facilitate the discovery, safeguard the intellectual property, and enable the commercialization of scientific research, innovations, and established brands. The company's portfolio includes the extensive Web of Science suite, a collection of essential tools such as Web of Science, InCites, Journal Citation Reports, EndNote, ScholarOne, Converis, Publons, and Kopernio. These are designed to support organizations throughout the entire research lifecycle, from initial planning and funding to execution and utilization. Within the Life Sciences domain, Clarivate provides specialized products like Cortellis and Newport Integrity. These platforms cater to pharmaceutical and biotechnology companies, empowering their research endeavors, supplying vital market intelligence, and facilitating competitive monitoring during the development and launch phases of novel drugs. Its Derwent product line, comprising Derwent Innovation, Techstreet, and IP Professional Services, is dedicated to intellectual property management. These tools enable customers to evaluate the originality of potential products, establish their freedom to operate within design parameters, secure patent protection, analyze the competitive technological landscape, and ensure adherence to essential industry standards. Complementing these, CompuMark delivers trademark screening, search, and monitoring solutions vital for businesses and legal firms. Meanwhile, MarkMonitor empowers enterprises to establish, manage, optimize, and fortify their digital presence. Clarivate's diverse clientele spans government agencies, academic institutions, life science enterprises, and research and development corporations worldwide, with operations across the Americas, Middle East, Africa, Europe, and Asia Pacific regions. The company, initially known as Clarivate Analytics Plc, rebranded to Clarivate Plc in May 2020. It maintains its headquarters in London, United Kingdom.
前日終値
$1.61
−$0.02 · -1.23%
日中の時刻はETです。市場データは遅延する場合があります。
Clarivate Plc operates as a prominent information services and analytics firm, furnishing structured data and insights. Its core mission is to facilitate the discovery, safeguard the intellectual property, and enable the commercialization of scientific research, innovations, and established brands. The company's portfolio includes the extensive Web of Science suite, a collection of essential tools such as Web of Science, InCites, Journal Citation Reports, EndNote, ScholarOne, Converis, Publons, and Kopernio. These are designed to support organizations throughout the entire research lifecycle, from initial planning and funding to execution and utilization. Within the Life Sciences domain, Clarivate provides specialized products like Cortellis and Newport Integrity. These platforms cater to pharmaceutical and biotechnology companies, empowering their research endeavors, supplying vital market intelligence, and facilitating competitive monitoring during the development and launch phases of novel drugs. Its Derwent product line, comprising Derwent Innovation, Techstreet, and IP Professional Services, is dedicated to intellectual property management. These tools enable customers to evaluate the originality of potential products, establish their freedom to operate within design parameters, secure patent protection, analyze the competitive technological landscape, and ensure adherence to essential industry standards. Complementing these, CompuMark delivers trademark screening, search, and monitoring solutions vital for businesses and legal firms. Meanwhile, MarkMonitor empowers enterprises to establish, manage, optimize, and fortify their digital presence. Clarivate's diverse clientele spans government agencies, academic institutions, life science enterprises, and research and development corporations worldwide, with operations across the Americas, Middle East, Africa, Europe, and Asia Pacific regions. The company, initially known as Clarivate Analytics Plc, rebranded to Clarivate Plc in May 2020. It maintains its headquarters in London, United Kingdom.
日中レンジ
現在 $1.61
52週レンジ
現在 $1.61
日中の時刻はETです。市場データは遅延する場合があります。
GoAI スコア
売り
バリュエーション
45
適正価値
センチメント
66
強気
リスク
69
高リスク
モメンタム
29
弱含み
GoAIの詳細リサーチ
詳しい根拠、カタリスト、リスクを確認できます。
Clarivate Plc operates as a prominent information services and analytics firm, furnishing structured data and insights. Its core mission is to facilitate the discovery, safeguard the intellectual property, and enable the commercialization of scientific research, innovations, and established brands. The company's portfolio includes the extensive Web of Science suite, a collection of essential tools such as Web of Science, InCites, Journal Citation Reports, EndNote, ScholarOne, Converis, Publons, and Kopernio. These are designed to support organizations throughout the entire research lifecycle, from initial planning and funding to execution and utilization. Within the Life Sciences domain, Clarivate provides specialized products like Cortellis and Newport Integrity. These platforms cater to pharmaceutical and biotechnology companies, empowering their research endeavors, supplying vital market intelligence, and facilitating competitive monitoring during the development and launch phases of novel drugs. Its Derwent product line, comprising Derwent Innovation, Techstreet, and IP Professional Services, is dedicated to intellectual property management. These tools enable customers to evaluate the originality of potential products, establish their freedom to operate within design parameters, secure patent protection, analyze the competitive technological landscape, and ensure adherence to essential industry standards. Complementing these, CompuMark delivers trademark screening, search, and monitoring solutions vital for businesses and legal firms. Meanwhile, MarkMonitor empowers enterprises to establish, manage, optimize, and fortify their digital presence. Clarivate's diverse clientele spans government agencies, academic institutions, life science enterprises, and research and development corporations worldwide, with operations across the Americas, Middle East, Africa, Europe, and Asia Pacific regions. The company, initially known as Clarivate Analytics Plc, rebranded to Clarivate Plc in May 2020. It maintains its headquarters in London, United Kingdom.
日中レンジ
現在 $1.61
52週レンジ
現在 $1.61
利用可能な期間全体で報告されたマージン。
売上高
営業利益
純利益
| 指標（USD） | 2025年度 | 2024年度 | 2023年度 | 2022年度 | 2021年度 |
|---|---|---|---|---|---|
| 売上高 | 24.55億 USD | 25.57億 USD | 26.29億 USD | 26.6億 USD | 18.77億 USD |
| 売上原価 | 8.34億 USD | 8.69億 USD | 9.06億 USD | 9.54億 USD | 6.26億 USD |
| 粗利益 | 16.22億 USD | 16.88億 USD | 17.22億 USD | 17.06億 USD | 12.51億 USD |
| 販売・一般管理 | 7.09億 USD | 7.28億 USD | 7.4億 USD | 7.3億 USD | 6.43億 USD |
| 営業費用 | 15.5億 USD | 19.63億 USD | 24.57億 USD | 56.31億 USD | 13.38億 USD |
| 支払利息 | 2.65億 USD | 2.83億 USD | 2.94億 USD | 2.7億 USD | 2.53億 USD |
| 減価償却費と償却費 | 7.57億 USD | 7.27億 USD | 7.08億 USD | 7.11億 USD | 5.38億 USD |
| 営業利益 | 7150万 USD | −2.76億 USD | −7.35億 USD | −39.26億 USD | −8700万 USD |
| 純利益 | −2.01億 USD | −6.37億 USD | −9.11億 USD | −39.6億 USD | −2.71億 USD |
会社概要が更新されました 2026年10月11日.
直近の発表実績
直近の発表実績
第三者のアナリスト予想は変更される場合があり、GoAIの推奨ではありません。
平均目標
$2.00
上昇余地（24.22%）この株式へのエクスポージャーを報告している上場投資信託です。
Avantis U.S. Small Cap Value ETFAVUV2593.13万0.08%308.51億 USD0.25%$119.64-0.41%
iShares Russell 2000 ETFIWM1519.33万0.02%787.4億 USD0.19%$278.94+0.49%
U.S. Small Cap Value Portfolio ETF Class SharesDFSV1206.06万0.04%268.09億 USD0.33%$37.95-0.39%
Vanguard Extended Market ETFVXF1021.04万0.01%954億 USD0.05%$235+0.80%
Dimensional - US Targeted Value ETFDFAT423.33万0.01%301.22億 USD0.33%$67.27-0.43%
Vanguard Russell 2000 ETFVTWO412.28万0.02%180億 USD0.06%$112.66+0.50%
Schwab Fundamental U.S. Small Company Index ETFFNDA386.91万0.04%87.82億 USD0.25%$35.62+0.17%
EA Bridgeway Omni Small-Cap Value ETFBSVO384万0.16%23.91億 USD0.45%$28.37-0.64%Avantis U.S. Small Cap Value ETFAVUViShares Russell 2000 ETFIWMU.S. Small Cap Value Portfolio ETF Class SharesDFSVVanguard Extended Market ETFVXFDimensional - US Targeted Value ETFDFATVanguard Russell 2000 ETFVTWOSchwab Fundamental U.S. Small Company Index ETFFNDAEA Bridgeway Omni Small-Cap Value ETFBSVOAIが生成した遅延市場データを、情報提供および教育目的で掲載しています。投資助言ではありません。
